CE
INSIDER · DNTH · Dianthus Therapeutics, Inc. /DE/ · CHIEF ACCOUNTING OFFICER
CARR EDWARD
Every open-market transaction filed under this name, Sep 17 to Sep 17.
Filings
5
0 buys · 5 sells
Bought
—
open market, at cost
Sold
$2M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 17 | DNTH | Dianthus Therapeutics, Inc. /DE/ | CHIEF ACCOUNTING OFFICER | Sell | 700 | $104.39 | $73K | — |
| Sep 17 | DNTH | Dianthus Therapeutics, Inc. /DE/ | CHIEF ACCOUNTING OFFICER | Sell | 1,100 | $103.20 | $114K | — |
| Sep 17 | DNTH | Dianthus Therapeutics, Inc. /DE/ | CHIEF ACCOUNTING OFFICER | Sell | 3,501 | $102.39 | $358K | — |
| Sep 17 | DNTH | Dianthus Therapeutics, Inc. /DE/ | CHIEF ACCOUNTING OFFICER | Sell | 6,771 | $101.37 | $686K | — |
| Sep 17 | DNTH | Dianthus Therapeutics, Inc. /DE/ | CHIEF ACCOUNTING OFFICER | Sell | 7,928 | $100.43 | $796K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.